Inmune Bio (INMB) Retained Earnings (2017 - 2025)
Historic Retained Earnings for Inmune Bio (INMB) over the last 9 years, with Q3 2025 value amounting to -$203.8 million.
- Inmune Bio's Retained Earnings fell 3241.82% to -$203.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$203.8 million, marking a year-over-year decrease of 3241.82%. This contributed to the annual value of -$163.1 million for FY2024, which is 3477.22% down from last year.
- Inmune Bio's Retained Earnings amounted to -$203.8 million in Q3 2025, which was down 3241.82% from -$197.3 million recorded in Q2 2025.
- In the past 5 years, Inmune Bio's Retained Earnings ranged from a high of -$37.9 million in Q1 2021 and a low of -$203.8 million during Q3 2025
- In the last 5 years, Inmune Bio's Retained Earnings had a median value of -$104.1 million in 2023 and averaged -$111.8 million.
- As far as peak fluctuations go, Inmune Bio's Retained Earnings plummeted by 9090.64% in 2021, and later plummeted by 3089.51% in 2025.
- Quarter analysis of 5 years shows Inmune Bio's Retained Earnings stood at -$63.7 million in 2021, then crashed by 42.85% to -$91.0 million in 2022, then crashed by 32.97% to -$121.0 million in 2023, then tumbled by 34.77% to -$163.1 million in 2024, then dropped by 24.93% to -$203.8 million in 2025.
- Its Retained Earnings stands at -$203.8 million for Q3 2025, versus -$197.3 million for Q2 2025 and -$172.8 million for Q1 2025.